Smith Group Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,120
Closed -$22K 407
2021
Q2
$22K Hold
2,120
﹤0.01% 228
2021
Q1
$25K Sell
2,120
-56,580
-96% -$642K ﹤0.01% 188
2020
Q4
$534K Buy
58,700
+15,390
+36% +$119K 0.03% 130
2020
Q3
$264K Sell
43,310
-40
-0.1% -$305 0.01% 155
2020
Q2
$385K Buy
43,350
+14,520
+50% +$125K 0.02% 142
2020
Q1
$209K Hold
28,830
0.01% 160
2019
Q4
$254K Hold
28,830
0.01% 180
2019
Q3
$176K Buy
+28,830
New +$162K 0.01% 203

Other funds holding NPTN

Smith Group Asset Management's NPTN Position: Q3 2021 in Review

Smith Group Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2021, closing a stake of 2,120 shares — an estimated $22K sold.

Smith Group Asset Management first reported a position in NPTN in Q3 2019 and held it in 8 quarters. The position peaked at $534K in Q4 2020. 124 funds tracked by Wall St. Rank hold NPTN as of Q3 2021.

  • Smith Group Asset Management reported no remaining NEOPHOTONICS CORP position as of Q3 2021 after selling out during the quarter.
  • Smith Group Asset Management sold 2,120 NEOPHOTONICS CORP shares in Q3 2021, an estimated $22K.
  • Smith Group Asset Management first reported a position in NEOPHOTONICS CORP in Q3 2019 and held it in 8 quarters.
  • Smith Group Asset Management's NEOPHOTONICS CORP position peaked at $534K in Q4 2020.
  • 124 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2021.

Based on Smith Group Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.